| scholarly article | Q13442814 |
| P50 | author | Graham R. V. Hughes | Q73300356 |
| Azzudin E. Gharavi | Q73597624 | ||
| P2093 | author name string | Boey ML | |
| Colaco CB | |||
| Elkon KB | |||
| Loizou S | |||
| P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| Studies on the Coagulation Defect in a Case of Thrombocytopenic Purpura Complicated by Thrombosis. | Q33387377 | ||
| The occurrence of circulating anticoagulants in patients with syphilitic and biologically false positive antilipoidal antibodies | Q33466923 | ||
| The clotting defect in SLE. | Q33481801 | ||
| Thrombosis in patients with the lupus anticoagulant | Q33486691 | ||
| Reduced prostacyclin activity in systemic lupus erythematosus | Q33552720 | ||
| Acquired inhibitors of blood coagulation | Q34699318 | ||
| Circulating anticoagulants: a study of 40 cases and a review of the literature. | Q35323162 | ||
| Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant | Q37027827 | ||
| Circulating Anticoagulants | Q39912914 | ||
| Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus. | Q47902320 | ||
| Circulating anticoagulant in disseminated lupus erythematosus. Proposed mode of action | Q48708671 | ||
| The coagulation abnormalities in systemic lupus erythematosus. | Q53745784 | ||
| A clinical study of the lupus anticoagulant | Q67808541 | ||
| Possible relationship between lupus inhibitor and recurrent abortion in young women | Q72429038 | ||
| Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation | Q72451284 | ||
| Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases | Q74457175 | ||
| The natural history of systemic lupus erythematosus: An approach to its study through chronic biologic false positive reactors | Q78586421 | ||
| The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies | Q78981048 | ||
| P433 | issue | 6398 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| lupus erythematosus | Q188297 | ||
| anticoagulant | Q215118 | ||
| thrombosis | Q261327 | ||
| anticoagulation | Q63279445 | ||
| P1104 | number of pages | 3 | |
| P304 | page(s) | 1021-1023 | |
| P577 | publication date | 1983-10-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant | |
| P478 | volume | 287 |
| Q38008403 | 'Overlap' syndromes |
| Q69737010 | A common anti-cardiolipin antibody idiotype in autoimmune disease: identification using a mouse monoclonal antibody directed against a naturally-occurring anti-phospholipid antibody |
| Q40494782 | Accelerated hypertension and nephroangiosclerosis associated with antiphospholipid syndrome. Report of two cases and review of the literature |
| Q93515633 | Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases |
| Q33555639 | Acute systemic lupus erythematosus with fatal pneumonitis and disseminated intravascular coagulation |
| Q88984101 | An extraordinary case of recurrent stroke, disseminated thrombosis and endocarditis |
| Q68096998 | Anti-Klebsiella K30 phospholipid antibodies in systemic lupus erythematosus: antigen cross-reactions and idiotypic sharing with antibodies to DNA and Klebsiella K30 polysaccharide |
| Q72565198 | Anti-Ro antibodies and abortions in women with SLE |
| Q53316978 | Anti-cardiolipin, anti-cardiolipin plus bovine, or human beta(2)glycoprotein-I and anti-human beta(2)glycoprotein-I antibodies in a healthy infant population. |
| Q69874910 | Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events |
| Q68026186 | Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus |
| Q69676875 | Anticardiolipin antibodies in Behçet's syndrome: a predictor of a more severe disease |
| Q33423945 | Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations |
| Q36707524 | Anticardiolipin antibodies--clinical associations |
| Q28261335 | Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus |
| Q33456927 | Anticardiolipin antibodies: isotype distribution and phospholipid specificity |
| Q24514516 | Anticardiolipin antibodies: occurrence in Behçet's syndrome |
| Q33556284 | Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal |
| Q48114647 | Antiphospholipid antibodies and cerebral artery dissection: two frequent causes of brain ischemia in young adults |
| Q73086663 | Antiphospholipid antibodies and the antiphospholipid antibody syndrome |
| Q72567741 | Antiphospholipid antibodies in acute Guillain-Barré syndrome |
| Q33406476 | Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients |
| Q35104711 | Antiphospholipid antibodies: discovery, definitions, detection and disease |
| Q69646451 | Antiphospholipid antibody syndrome with right atrial thrombosis mimicking an atrial myxoma |
| Q55462735 | Antiphospholipid antibody syndrome: a review. |
| Q38841201 | Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria? |
| Q41241672 | Antiphospholipid syndrome: five year follow up |
| Q73103175 | Antiphospholipid thrombosis syndromes |
| Q34551369 | Autoantibodies in lupus and its variants: experience in 1000 patients. |
| Q35172086 | Autoantibody-mediated atherosclerosis |
| Q70333170 | Autoanticoagulation does not preclude pulmonary emboli |
| Q69493179 | Autoimmune disease in pregnancy |
| Q33561944 | Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities |
| Q39689349 | Bleeding and coagulation disorders in the elderly |
| Q33556669 | Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with the lupus anticoagulant |
| Q68795240 | C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE) |
| Q33492697 | Calorie restriction prevents the occlusive coronary vascular disease of autoimmune (NZW x BXSB)F1 mice |
| Q48295399 | Cardioembolic caudate infarction as a cause of hemichorea in lupus anticoagulant syndrome |
| Q39831064 | Cerebral disease in systemic lupus erythematosus |
| Q31113281 | Cerebral infarct associated with lupus anticoagulant in an adolescent girl: A case report with review of the literature |
| Q43629550 | Cerebral ischemia associated with anticardiolipin antibodies |
| Q33562091 | Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus |
| Q71808661 | Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS) |
| Q33627995 | Chorea and the lupus anticoagulant |
| Q68354952 | Circulating anticoagulants excluding hemophilia. Multicenter survey undertaken under the aegis of the French National Society of Internal Medicine apropos of 207 cases |
| Q70280157 | Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease |
| Q33562708 | Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus |
| Q33448275 | Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus |
| Q33567067 | Controversies in lupus: nervous system involvement |
| Q69890603 | Coronary artery bypass graft failure--an autoimmune phenomenon? |
| Q40841563 | Current insights into the "antiphospholipid" syndrome: clinical, immunological, and molecular aspects |
| Q72825269 | Current understanding of systemic lupus erythematosus |
| Q34552474 | Degos' disease: association with anticardiolipin antibodies and the lupus anticoagulant |
| Q33477702 | Diagnosis and treatment of recurrent venous thromboembolism |
| Q33557343 | Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities |
| Q33416958 | Fetal loss treatment in patients with antiphospholipid antibodies. |
| Q70510212 | Further immunological studies of sera containing anti-mitochondrial antibodies, type M 5 |
| Q72567738 | Hepatic veno-occlusive disease due to toxic alkaloid herbal tea |
| Q44440961 | Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis |
| Q68134484 | High aortic occlusion associated with lupus anti-coagulant |
| Q33374342 | Hypercoagulability syndromes: what the dentist needs to know |
| Q43638228 | IgG and IgM anti-endothelial cell antibodies in patients with collagen-vascular disorders |
| Q33379907 | Immunology and Clinical Importance of Antiphospholipid Antibodies |
| Q39507052 | Immunopathogenesis of the neuropsychiatric manifestations of systemic lupus erythematosus |
| Q69264400 | Inadequate periods of anticoagulation in the 'lupus anticoagulant syndrome'--a case report |
| Q33560401 | Indications of vascular endothelial cell dysfunction in systemic lupus erythematosus |
| Q35822651 | Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H). |
| Q33999868 | Intracardiac thrombosis, phospholipid antibodies, and two-chambered right ventricle |
| Q33498334 | Isolation and purification of anticardiolipin antibody from plasma of a patient with antiphospholipid syndrome: induced generation of platelet thromboxane A2 synthesis |
| Q33392824 | Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients |
| Q37963792 | Laboratory diagnosis of the lupus anticoagulant |
| Q35683849 | Lupus anticoagulant (LA) in pregnant women with history of recurrent fetal loss |
| Q44539185 | Lupus anticoagulant and cerebral infarction: therapeutic implications |
| Q39849377 | Lupus anticoagulant and pregnancy |
| Q72573870 | Lupus anticoagulant and thrombosis in systemic lupus erythematosus |
| Q33446982 | Lupus anticoagulant associated syndrome in benign and malignant systemic disease |
| Q33447033 | Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observations |
| Q71914828 | Lupus anticoagulant in patients with peripheral vascular disease: a prospective study |
| Q72565195 | Lupus anticoagulant, recurrent abortion, and prostacyclin production by cultured smooth muscle cells |
| Q33393751 | Lupus anticoagulants in systemic lupus erythematosus: prevalence and clinical associations |
| Q34499518 | Lupus vasculitis: differential diagnosis with antiphospholipid syndrome |
| Q70376785 | Management of retinal vein occlusion |
| Q68623953 | Massive hepatic infarction in systemic lupus erythematosus |
| Q33375406 | Mechanisms of aPL-mediated thrombosis: effects of aPL on endothelium and platelets |
| Q37111561 | Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus |
| Q33447611 | Monoclonal hybridoma anti-cardiolipin antibodies from SLE mice. |
| Q35605240 | Multiple thromboses in systemic lupus erythematosus |
| Q33446337 | Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid |
| Q36998932 | New targeted therapies for treatment of thrombosis in antiphospholipid syndrome |
| Q41220259 | Occlusive ocular vascular disease and antiphospholipid antibodies |
| Q77796443 | Opposite beta2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity |
| Q35309024 | Pathophysiology of the antiphospholipid antibody syndrome |
| Q39600335 | Phenothiazine-associated lupus anticoagulant and thrombotic disease |
| Q37846415 | Platelet phospholipid antigen-antibody interactions: detection and biological relevance. |
| Q39594752 | Pregnancy in lupus nephritis and related disorders. |
| Q33376853 | Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: a prospective study |
| Q36681618 | Prevalence of anticardiolipin antibodies in the elderly British population |
| Q72355315 | Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus |
| Q86527461 | Prevention of recurrent stroke in patients with systemic lupus erythematosus or lupus anticoagulant |
| Q34283657 | Prostacyclin deficiency in a young woman with recurrent thrombosis |
| Q38739269 | Protein-losing enteropathy in systemic lupus erythematosus. Observations by magnifying endoscopy |
| Q33561173 | Pulmonary haemorrhage, pulmonary infarction, and the lupus anticoagulant |
| Q51859166 | Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. |
| Q77903286 | Pulmonary manifestations of systemic lupus erythematosus |
| Q38160857 | Recent advances in laboratory tests and the significance of autoantibodies to nuclear antigens in systemic rheumatic diseases. |
| Q37820885 | Recurrent adverse pregnancy outcome and antiphospholipid antibodies |
| Q33562467 | Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome |
| Q30701440 | Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature |
| Q33379174 | Review of Hypercoagulability Syndromes: What the Interventionalist Needs to Know |
| Q70172084 | Rheumatology |
| Q24563574 | Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitro |
| Q42591380 | Severe hypotension due to epoprostenol |
| Q68037788 | Splenic and renal infarction in systemic lupus erythematosus: association with anti-cardiolipin antibodies |
| Q72573866 | Stress, cortisol, and lymphocyte subpopulations |
| Q35530248 | Systemic lupus erythematosus and thrombosis |
| Q39756290 | Systemic lupus erythematosus clinical issues |
| Q38046207 | Systemic lupus erythematosus for general practitioners: a literature review |
| Q55084099 | Systemic lupus erythematosus with anticardiolipin antibodies and lupus anticoagulant syndrome. |
| Q33556000 | Tetraplegia as a presenting feature of systemic lupus erythematosus complicated by pulmonary hypertension. |
| Q33393937 | The 'antiphospholipid syndrome' and the 'lupus anticoagulant'. |
| Q70302590 | The Budd-Chiari syndrome. Possible pathogenetic role of anti-phospholipid antibodies |
| Q40544880 | The antiphospholipid and thrombosis (APL-T) syndromes. Clinical and laboratory correlates. |
| Q37891187 | The antiphospholipid antibody dilemma |
| Q72818973 | The antiphospholipid syndrome |
| Q38374306 | The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome |
| Q33555478 | The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension |
| Q36229639 | The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies |
| Q33367609 | The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses |
| Q35966558 | The role of antiphospholipid antibodies in stroke. |
| Q33371184 | The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients |
| Q28188901 | Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease |
| Q45773581 | Three cases of varicella thrombophlebitis as a complication of varicella zoster virus infection |
| Q24675412 | Thrombosis, abortion, cerebral disease, and the lupus anticoagulant |
| Q44254106 | Umbilical and Uterine Artery Flow Velocity Waveforms in Pregnant Women With Systemic Lupus Erythematosus Treated With Aspirin and Glucocorticosteroids |
| Q44583525 | Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). |
| Q70213119 | Vaso-occlusive retinopathy in the primary anti-phospholipid antibody syndrome |
| Q70406514 | Visual symptoms associated with the presence of a lupus anticoagulant |
| Q34354700 | Which antiphospholipid antibody tests are most useful? |
| Q68917663 | [Antiprothrombinase and myocardial infarction. Apropos of 2 cases] |
| Q69983908 | [Circulating anticoagulants. Clinical conditions of diagnosis] |
| Q83443423 | [Epidemiology of menometrorrhagia] |
| Q64390372 | [Is the target of anti-cardiolipin antibodies the same in Gougerot-Sjögren syndrome and lupus erythematosus disseminatus?] |
Search more.